Email
Print
2-Fucosyllactose Market Overview
The 2-Fucosyllactose
market size was estimated at $31.23 million in 2021, growing at a CAGR of 8.02%
during the forecast period 2022-2027. Human milk is
very important for infants' good nutrition and immune system development.
2'Fucosyllactose is one of the numerous forms of oligosaccharides found in
human milk that also contain microbiota. 2'Fucosyllactose is a trisaccharide
made up of galactose, glucose, and fucose, which is a form of oligosaccharide.
It is the most significant of all the oligosaccharides, and is necessary for
the infant's body to receive proper nutrition.
Furthermore, 2'Fucosyllactose boosts newborns' general
anti-infective capacity. The 2'Fucosyllactose can be taken by people of all
ages, however, the percentage consumed varies by age. 2'Fucosyllactose is
critical for reducing the risk of infections such as viral, bacterial, and
other illnesses. The increasing
awareness about the benefits of 2-Fucosyllactose
is one of the major factors driving the growth of the market. Growing
inclination towards food supplements in daily diet is set to further enhance
the overall market development of the 2-Fucosyllactose Market for the period
2022-2027.
Report Coverage
The report: “2-Fucosyllactose Market Forecast
(2022-2027)”, by Industry ARC, covers an in-depth
analysis of the following segments of the 2-Fucosyllactose Market.
By Form: Powder and Liquid
By Nature: Organic and Conventional
By
End-User: Food & Beverage, Infant Formula,
Pharmaceutical and Dietary
Supplements.
By
Distribution Channel: Hypermarkets/Supermarkets, Convenience Store,
Speciality Store, Online Retailers, and others.
By Geography: North America
(U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia,
and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia,
and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina,
and Rest of South America), and Rest of the World (the Middle East, and Africa)
Key Takeaways
- North America dominated the 2-Fucosyllactose Market in 2021 owing to rising awareness about a healthy diet for an infant in this region. The 2-Fucosyllactose Market scope for different regions will be provided in the final report.
- Increasing investment
in R&D by key manufacturers is set to aid the market growth of the 2-Fucosyllactose
Market report.
- Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the 2-Fucosyllactose Market report.
2-Fucosyllactose Market Revenue Share, By Geography, 2021(%)
For More Details on This Report - Request for Sample
2-Fucosyllactose Market Segment Analysis – By End-User
Based on end-user,
the market for 2-Fucosyllactose is segmented into Food & Beverage, Infant Formula, Pharmaceutical, and Dietary Supplements.
Dietary supplements have the largest share in the 2-Fucosyllactose
market in 2021 and also it is estimated to register a higher CAGR of 10.07%
during the forecast period 2022-2027. 2-Fucosyllactose is widely used in infant nutrition and as a dietary supplement to support the
digestive and immune health of the infant. It increases the anti-infecting
capacity of infants. The 2'Fucosyllactose is essential in preventing infections
such as viral, bacterial, and other diseases. Additionally, the increasing inclination of consumers towards dietary
supplements is increasing the
2-Fucosyllactose market.
2-Fucosyllactose Market Segment
Analysis – By Distribution
Channel
Based on
end-user, the market for 2-Fucosyllactose is categorized in Hypermarkets/Supermarkets,
Convenience Store, Speciality Store, Online Retailers, and others. Hypermarkets/Supermarkets held the largest share in the 2-Fucosyllactose market in 2021. Supermarkets/Hypermarkets offer better
brand visibility, separate baby sections, an easy shopping experience, and the
availability of a wide range of products and brands that increase the 2-Fucosyllactose market. However, Online retailer is estimated to register a higher CAGR of 11.0% during the forecast
period 2022-2027 owing to Online Retail Stores providing more discounts and
wider options to purchase with diverse product portfolio.
2-Fucosyllactose Market Segment Analysis – By Geography
North America dominated
the 2-Fucosyllactose market with a major share of 41% in 2021. This is
attributed to the increasing awareness about the health benefits of 2-Fucosyllactose in this region as it is
considered safe for infant nutrition. Furthermore, the presence
of key manufacturers in this region are introducing innovative products
contributing to the growth of the market in this region.
However, Asia
Pacific is estimated to grow at a higher CAGR during the forecast period
2022-2027 owing to rising health concerns about gut diseases and other diseases
in this region. Increasing the
spending capacity of the people in this region is also increasing the growth of
the market in this region.
2-Fucosyllactose Market Drivers
Increasing Research & Development and Introduction of New Products by Key Players
Increasing research & development as well as the launch of a new innovative product by key players across the globe is increasing the growth of the 2-Fucosyllactose Market. For instance, in 2019, BASF launched 2-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO) for infant nutrition through its human nutrition brand, Newtrition. Additionally, a growing preference towards a healthy diet on daily basis among people is also predicted to increase the growth of the 2-Fucosyllactose market during the forecast period 2022-2027.
Growing Acceptance of Human milk oligosaccharides (HMOs) Owing to Its Health Benefits
Increasing acceptance
of Human milk
oligosaccharides (HMOs) among consumers owing to its several benefits such as
it protects against several viral pathogens are increasing the growth of the 2-Fucosyllactose
market. The primary
components of human milk are oligosaccharides, which come in a variety of
compositions and quantities. Consumption of HMOs helps in the reduction of
infant mortality rate. According to, According
to the United Nations International Children's Education Fund (UNICEF), the
mortality rate for children under the age of five was one in 11 in 1990 and one
in 26 in 2018. Moreover, the rising concern about gut diseases is increasing
the growth of the 2-Fucosyllactose Market during the forecast period 2022-2027.
2-Fucosyllactose Market Challenges
High Cost of Product and Stringent Rules and regulations
The major
factor that is set to impede the growth of the 2-Fucosyllactose market is the high
cost of the 2-Fucosyllactose product owing to high production expenses. For
instance, manufacturers are generating 2-Fucosyllactose, human milk
oligosaccharides(HMO), using advanced technologies such as chemical and
enzymatic synthesis. These synthetic and enzymatic procedures require a high
amount of capital and energy, which increases the overall cost of the product. Another
factor that hampers the growth of the market is strict government rules and
regulations to launch a new product along with the complicated process
regarding the registration of new products.
Market Landscape
Product
launches, mergers and acquisitions, joint ventures, and R&D activities are
key strategies adopted by players in the 2-Fucosyllactose Market. In 2021, the 2-Fucosyllactose
Market share is consolidated by the top ten players present in the market. In the 2-Fucosyllactose
Market, the top 10 companies encompass:
- Nestle S.A
- Abbott Laboratories
- Jennewein Biotechnologie GmbH
- GNUbiotics Sciences
- FreislandCampina Ingredients
- Glycosyn LLC
- The Honest Co
- Elicityl SA
- Dextra Group
- The Hain Celestial Group Inc.
Development:
In March 2021, BASF’s PREBILAC, the first 2’-Fucosyllactose (2’-FL) ingredient received
Australia’s Therapeutic Goods Administration approval. For the next two years,
BASF will have exclusive rights to supply 2'-FL, a human milk oligosaccharide
(HMO) for use in nutritional supplements in Australia.
Relevant Titles:
Gluten Free Food Market - Forecast(2021 -
2026)
Report Code: FBR 0047
Lactose Free Food Market - Forecast(2021 -
2026)
Report Code: FBR 0040
For more Food and Beverage Market related reports, please click here